|
Another thought.
Tamoxifen has been suggested in trials to be a percusor (increase rather than decrease risk) in women that express high levels of cyclin D1 (from memory), and for another group of which I do not recall the details.
Details of both can be found on this site using the search facility above. These are clearly complex issues and the best strategy might be to find them print them out and discuss with you advisors in case they have any relevance.
RB
|